TY - JOUR T1 - A Rare Adverse Effect Of Montelukast Treatment: Ecchymosis JF - Respiratory Care DO - 10.4187/respcare.02298 SP - respcare.02298 AU - Cenk Aypak AU - Özlem Türedi AU - Nisa Solmaz AU - Hülya Yıkılkan AU - Süleyman Görpelioğlu Y1 - 2013/01/15 UR - http://rc.rcjournal.com/content/early/2013/01/15/respcare.02298.abstract N2 - Montelukast is a leukotriene receptor antagonist that has been found to be effective in the treatment of allergic rhinitis and asthma. We report a rare case of a 31-year-old woman, with a history of allergic rhinitis and moderate persistent asthma, who experienced severe bruising on her lower extremities after starting montelukast treatment. Clinicians should be aware of the possibility of unusual bruising during montelukast therapy, and in those patients, treatment with montelukast should be discontinued. ER -